Breaking News
Get 55% Off 0
👀 Ones to watch: The MOST undervalued stocks to buy right now
See Undervalued Stocks
Close

Nova Steady Healthcare P (0P000156VT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
107.020 +1.920    +1.83%
22/11 - Closed. Currency in EUR
Type:  Fund
Market:  Germany
Issuer:  Universal-Investment GmbH
ISIN:  DE000A1145J0 
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 8.44M
nova Steady HealthCare P 107.020 +1.920 +1.83%

Nova Steady Healthcare P Overview

 
On this page you'll find an in-depth profile of Nova Steady Healthcare P. Learn about the key management, total assets, investment strategy and contact information of 0P000156VT among other information.
Category

Sector Equity Healthcare

Total Assets

8.44M

Expenses

2.41%

Inception Date

Apr 01, 2015

Investment Strategy

The objective of the fund's investment strategy is to achieve an appropriate, long-term increase in the value of the investments. The assets to be acquired for the fund are identified on a discretionary basis on the basis of the consistent investment process described below ("active management"). The Company does not use a benchmark index for the management of the Fund because it believes that focusing on a variable portfolio composition is the best means of implementing the investment strategy.The Company actively decides on the selection of assets at its discretion, taking into account analyses and valuations of companies as well as economic and political developments. At least 51 percent of the fund is composed of equities of companies whose main focus of activity is in the health care sector.

Contact Information

Address 15, rue de Flaxweiler L-6776 Grevenmacher
Grevenmacher, L-6776
Luxembourg
Phone +352 769 494602
Fax +352 769494-800

Top Executives

Name Title Since Until
Not Disclosed - 2015 Now
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P000156VT Comments

Write your thoughts about Nova Steady Healthcare P
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email